No Data
No Data
No Data
Biohaven Currently Down Nine Consecutive Days, on Track for Longest Losing Streak on Record -- Data Talk
Optimistic Outlook: Buy Rating on Biohaven Ltd. for Strategic Approach and Promising R&D Pipeline
Express News | Biohaven Ltd: Filed a Prospectus Supplement to Its Registration Statement on Form S-3 Filed With SEC
Express News | Biohaven Ltd - May Offer and Sell Common Shares of up to $300.0 Mln From Time to Time
Buy Rating Backed by Biohaven Ltd.'s Promising Clinical Pipeline and Pharmacokinetic Advancements
Express News | Biohaven Ltd : UBS Cuts Target Price to $54 From $55
No Data
No Data
Violets : great post
sTone83 OP Violets : ;His books has rewritten my understanding, and I've been grateful ever since.
MattSully : Thanks for re-posting MM’s posts bro. Very helpful.
MattSully : Can you figure out what CVHN is?
sTone83 OP MattSully : $Crinetics (CRNX.US)$
View more comments...